GLP-1 medicines and vision · Court order
Why one patient’s case stayed out of the GLP-1 eye-injury litigation
A patient withdrew his vision-loss allegation. A footnote in the December 2025 transfer order shows how that change affected which federal court proceeding could include his case.

In the Garcia lawsuit, the patient changed what he alleged. His amended complaint dropped a claim of vision loss and described only gastrointestinal injuries. When a federal panel set up a group of GLP-1 eye-injury cases on December 15, 2025, it explained in a footnote why Garcia’s case fell outside it.
What changed in the complaint
The panel identified Garcia by his case number, 2:25-cv-04537. Once he amended his complaint, the injury at the center of the proposed eye-injury proceeding was absent from his allegations. The panel listed his case separately on Schedule B.
Why there are two docket numbers
MDL 3094 already grouped lawsuits alleging gastrointestinal injuries. The panel created MDL 3163 for lawsuits alleging non-arteritic anterior ischemic optic neuropathy, commonly called NAION. Both proceedings went to Judge Karen S. Marston in the Eastern District of Pennsylvania. Separate dockets let the judge coordinate shared work while tracking the two sets of cases.
What the panel decided
The order assigned cases for pretrial proceedings. It left questions about what caused an individual patient’s injuries and whether a manufacturer was liable for later proceedings. For a reader tracing a headline, the injury alleged in the complaint helps identify the relevant docket.
